Cargando…
Human placental hematopoietic stem cell derived natural killer cells (CYNK-001) mediate protection against influenza a viral infection
Influenza A virus (IAV) infections are associated with a high healthcare burden around the world and there is an urgent need to develop more effective therapies. Natural killer (NK) cells have been shown to play a pivotal role in reducing IAV-induced pulmonary infections in preclinical models; howev...
Autores principales: | Gleason, Joseph, Zhao, Yuechao, Raitman, Irene, Kang, Lin, He, Shuyang, Hariri, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255201/ https://www.ncbi.nlm.nih.gov/pubmed/35404743 http://dx.doi.org/10.1080/21645515.2022.2055945 |
Ejemplares similares
-
Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Mediate Protection Against Influenza A Viral Infection
por: He, Shuyang, et al.
Publicado: (2020) -
Human placental hematopoietic stem cell-derived natural killer cells (CYNK) recognize and eliminate influenza A virus-infected cells
por: Gunasekaran, Manojkumar, et al.
Publicado: (2022) -
Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer
por: Zhu, Yahui, et al.
Publicado: (2022) -
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
por: Asmamaw Dejenie, Tadesse, et al.
Publicado: (2022) -
Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases
por: Hua, Chunting, et al.
Publicado: (2022)